Walleye Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-28,500
| Closed | -$260K | – | 5052 |
|
|
2025
Q2 | $260K | Buy |
+28,500
| New | +$210K | ﹤0.01% | 3170 |
|
|
2024
Q4 | – | Sell |
-7,500
| Closed | -$54.1K | – | 5460 |
|
|
2024
Q3 | $54.1K | Sell |
7,500
-16,900
| -69% | -$155K | ﹤0.01% | 4615 |
|
|
2024
Q2 | $265K | Buy |
24,400
+21,900
| +876% | +$281K | ﹤0.01% | 4082 |
|
|
2024
Q1 | $46.9K | Sell |
2,500
-13,100
| -84% | -$302K | ﹤0.01% | 4698 |
|
|
2023
Q4 | $338K | Buy |
15,600
+6,900
| +79% | +$137K | ﹤0.01% | 3277 |
|
|
2023
Q3 | $179K | Buy |
8,700
+5,300
| +156% | +$153K | ﹤0.01% | 3622 |
|
|
2023
Q2 | $160K | Buy |
+3,400
| New | +$169K | ﹤0.01% | 3216 |
|
|
2023
Q1 | – | Sell |
-3,600
| Closed | -$137K | – | 4301 |
|
|
2022
Q4 | $137K | Buy |
3,600
+100
| +3% | +$3.82K | ﹤0.01% | 2249 |
|
|
2022
Q3 | $137K | Buy |
+3,500
| New | +$135K | ﹤0.01% | 2289 |
|
|
2019
Q4 | – | Sell |
-37,800
| Closed | -$5.3M | – | 2203 |
|
|
2019
Q3 | $5.3M | Buy |
37,800
+36,300
| +2,420% | +$6.07M | 0.32% | 47 |
|
|
2019
Q2 | $275K | Buy |
+1,500
| New | +$256K | 0.03% | 778 |
|
Other funds holding SAGE
IA
HNB